HØRSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX:LCP) reported a net loss of DKK 69.1 million for the first nine months of 2008, compared to a net loss of DKK 87.9 million for the same period in 2007. This is in line with the expectations for 2008 which were announced in the Q2 2008 interim report of August 21, 2008.
